Blanche nomination regains momentum after agreement to revoke “anti-weaponization fund” and clarify immunity issues

Todd Blanche’s nomination appeared back on track after Blanche reached an agreement that would fully revoke President Donald Trump’s so-called “anti-weaponization fund,” and further clarify the contours of Trump’s limited immunity from prosecution tied to past alleged tax-related misconduct, according to a report from The Washington Times on Aug. 3, 2026. The development was described as helping Blanche secure enough support to advance through the Senate Judiciary Committee.

The report said Blanche reached agreement terms that would address two issues that had become central to committee-level review. One involves the stated plan associated with Trump’s “anti-weaponization fund,” which critics and some senators had argued was intended to influence or respond to investigations in a way that raised constitutional and political concerns. The other centers on how Trump’s limited immunity from prosecution would be characterized for purposes of related legal questions discussed during the nomination process.

Blanche, the nominee at the center of the dispute, had faced scrutiny over the legal and political implications of those issues as senators weighed whether to move his nomination forward. The committee process has served as the venue for questions about appropriate deference to presidential authority, as well as the boundaries of independent legal decision-making by officials who would operate within the Justice Department system.

Under the agreement described by The Washington Times, Blanche would “fully” revoke the “anti-weaponization fund,” framing it as something that would no longer operate as originally described. The report also said the arrangement would “clarify” Trump’s limited immunity from prosecution, specifically referencing past tax malfeasance allegations that had been part of the broader legal debate around the limits of what a president can be prosecuted for after leaving office or while acting in an official capacity.

The practical effect, the report said, is that Blanche appeared to have enough backing to move forward through the Senate Judiciary Committee. It did not lay out a final vote result in the committee, but the language indicated that the agreement removed at least some of the objections that had stalled momentum.

As the nomination proceeds, the key next steps are likely to be further committee handling of Blanche’s nomination and any additional public questions or document requests connected to the agreement terms. The immunity clarification and the fund rescission, if reflected in formal commitments, would be expected to shape how senators and counsel interpret the nominee’s approach to executive-branch legal authority and prosecutorial boundaries.

Any ultimate confirmation outcome would still depend on the committee’s actions and the full Senate’s subsequent consideration. The agreement described Tuesday, however, marks a change in the negotiation posture around Blanche, shifting the immediate focus from the existence of the contested fund and immunity framing to whether senators consider the revised terms sufficient for approval to proceed.